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Connective tissues are ubiquitous throughout the body and consequently affect the function of many
organs. In load bearing connective tissues like tendon, the mechanical functionality is provided almost
exclusively by collagen fibrils that in turn are stabilized by covalent cross-links. Functionally distinct ten-
dons display different cross-link patterns, which also change with maturation, but these differences have
not been studied in detail at the fibril level. In the present study, a custom built nanomechanical test plat-
form was designed and fabricated to measure tensile mechanics of individual fibrils from rat tendons. The
influence of animal maturity (4 vs. 16 week old rats) and functionally different tendons (tail vs. Achilles
tendons) were examined. Additionally the effect of methylglyoxal (MG) treatment in vitro to form
advanced glycation end products (AGEs) was investigated. Age and tissue type had no significant effect
on fibril mechanics, but MG treatment increased strength and stiffness without inducing brittleness
and gave rise to a distinct three-phase mechanical response corroborating that previously reported in
human patellar tendon fibrils. That age and tissue had little mechanical effect, tentatively suggest that
variations in enzymatic cross-links may play a minor role after initial tissue formation.
Statement of significance
Tendons are connective tissues that connect muscle to bone and carry some of the greatest mechanical
loads in the body, which makes them common sites of injury. A tendon is essentially a biological rope
formed by thin strands called fibrils made of the protein collagen. Tendon function relies on the strength
of these fibrils, which in turn depends on naturally occurring cross-links between collagen molecules, but
the mechanical influence of these cross-links have not been measured before. It is believed that beneficial
cross-linking occurs with maturation while additional cross-linking with aging may lead to brittleness,
but this study provides evidence that maturation has little effect on mechanical function and that age-
related cross-linking does not result in brittle collagen fibrils.
 2018 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In most connective tissues the primary load bearing function is
provided by fibrillar collagens [1]. Collagen fibrils can form sponta-neously through non-covalent interactions by an organized stag-
gered aggregation of collagen molecules [2,3]. The mechanical
function of the fibrils and the tissues they form is believed to
depend on stabilization by covalent bonds called cross-links that
result from the activity of lysyl oxidase enzymes (LOX) [4–6].
The cross-links are formed in several steps; initially so-called
immature divalent bonds are formed, which can subsequently
react further to form different mature, trivalent bonds [7,8]. The
mature forms are stable to acids, while the immature cross-links
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[9].
In addition to the enzymatic cross-links, reducing sugars (e.g.
glucose) and certain metabolic products (e.g. methylglyoxal) can
react with proteins to produce various adducts, some of which
form cross-links [10,11]. The final products of such reactions are
called advanced glycation end products (AGEs), which accumulate
over time on long-lived proteins like collagens. A glucose derived
cross-linking AGE called glucosepane is currently believed to be
the major species accumulating on matrix proteins in vivo [12–
14]. Two methylglyoxal derived cross-links called MODIC and
MOLD have also been reported in vivo but at lower concentrations
[12–14]. Glucosepane and MODIC are both lysine-arginine cross-
links while MOLD links two lysines. The three cross-links are of
similar length but glucosepane is more bulky [13]. Unlike enzy-
matic cross-links, AGE formation can take place at multiple differ-
ent sites along the helical region of collagen molecules [15,16].
Glucosepane and MODIC are likely to form at the same sites, with
8 potential intermolecular lysine-arginine pairs having been
reported, in contrast MOLDmay be more likely to form intramolec-
ular bonds due to the proximity of lysine residues on the two iden-
tical alpha chains within the type I collagen molecule [16].
Enzymatic and AGE cross-links both contribute to the chemical
stability of collagen [17,18], and tissues tend to get mechanically
stronger with maturation, and weaker with inhibition of enzymatic
cross-links [19,20]. Induction of AGEs in vitro has also been associ-
ated with increased stiffness and strength [21,22], although in vivo
findings are inconsistent [23–26]. Glycation is thought to be detri-
mental to tissue function with brittleness and reduced strain
capacity [27], but there is little such evidence at the tissue level
[22]. However, brittleness may still be present at the fibril level,
which could result in fragmentation of the fibrils and thereby help
explain the reduced stiffness with aging.
Macroscopic mechanical properties can be affected by mecha-
nisms operating at different levels of the structural hierarchy, but
the influence of cross-links is expected to occur at the scale of indi-
vidual collagen fibrils, although this has never been conclusively
demonstrated. Mechanically testing individual fibrils is possible,
albeit technically challenging [28–32]. Absolute mechanical prop-
erties vary significantly between previous studies, but there is gen-
eral agreement that type I collagen fibrils display intrinsic
viscoelasticity [33–35]. Increased stiffness and strength have been
reported from different synthetic cross-links [35], but the influence
of naturally occurring enzymatic and AGE cross-links has not been
studied directly. Indirect measurements using x-ray diffraction
have shown that deficiency in enzymatic cross-links resulted in
reduced strength and stiffness [36], and that induction of AGEs
in vitro led to an increase in strength and strain without a change
in stiffness [37]. The x-ray diffraction technique is limited by fail-
ure of the macroscopic specimen, which may occur by mechanism
unrelated to fibril ultimate properties, and because details in the
fibril mechanical response may be blurred by averaging across a
large number of fibrils.
The present study aimed to investigate how enzymatic and AGE
cross-links affect fibril mechanics by studying the influence of ani-
mal maturation using immature (4 week old) and mature (16 week
old) rats, and functionally different tendons using tail and Achilles.
These factors relate indirectly to enzymatic cross-linking since ani-
mal maturation is associated with cross-link maturation [27], and
tail tendons are more acid labile than Achilles indicating lower
levels of stable immature and mature cross-links [38]. Samples
were treated with methylglyoxal (MG) in vitro to mimic AGE for-
mation at a supraphysiological level. A new mechanical device
was designed to investigate strain distribution along the fibril dur-
ing mechanical testing since fibril deformation may not be uniform
[39]. We hypothesized the following: a) mature enzymatic cross-linking would be greater in old compared to young rats, and
greater in Achilles compared to tail tendons, b) the stiffness and
strength of collagen fibrils would increase with increasing mature
enzymatic cross-linking, c) AGE induction by methylglyoxal would
increase stiffness and strength but decrease ultimate strain, result-
ing in more brittle collagen fibrils, and d) strain within fibrils
would be localized in distinct regions but become more uniform
with increased cross-linking.2. Materials and methods
2.1. Materials
Hind limbs and tails from 4 and 16 week old male Wistar rats
were obtained from Charles River (6 at each age). Individual fasci-
cles (macroscopic tendon subunits) were extracted from the tails
by cutting the distal end and pulling fascicles with tweezers
(Fig. 1). Only the two larger ventral bundles were used. In addition,
the free length of Achilles tendon was dissected from the hind
limbs. A single tail fascicle was obtained for fibril mechanics, and
divided transversely with one half treated with MG (Section 2.2).
Two fascicles were taken for macroscopic mechanical testing and
they were divided transversely with one distal and one proximal
part treated with MG. Several additional fascicles were extracted
and separated into small bundles (5 mg) for acid solubility, fluo-
rescence and cross-link measurements. Each bundle was divided
transversely and one half randomly assigned to MG treatment.
Each Achilles tendon was cut into three longitudinal strips and
divided transversely to get 6 pieces. The pieces were randomly
assigned with two for fibril mechanics and cross-links, two for acid
solubility and two for fluorescence, half of which were treated with
MG.
2.2. Methylglyoxal treatment
Half of the samples were treated with MG to induce AGEs in a
similar way as previously published by Li et al [40]. Treatment
was performed in a buffer of 100 mM EPPS (4-(2-hydroxyethyl)-1
-piperazinepropanesulfonic acid, E1894, Sigma-Aldrich), 150 mM
phosphate buffered saline (PBS) and 5 mM EDTA adjusted to pH
8.5. Control samples were treated with just the buffer and glycated
samples with the buffer including 20 mM MG (W296902, Sigma-
Aldrich). Each sample was treated in 1 mL solution at 36 C for
4.5 h. Following treatment, tissue was washed and stored frozen
(20 C) in PBS. Fascicle mechanics and fluorescence were mea-
sured within 3 months but due to time consuming method devel-
opment, fibril measurements were conducted after 2–3 years and,
for the sake of comparability, acid solubility and cross-links were
measured in this period as well.
2.3. Acid solubility
Chemical stability of collagen was assessed by acid solubility
[41]. Tissue pieces (1 mg wet weight) were lightly blotted to
remove excess liquid, finely minced with a scalpel and dissolved in
1 mL of 50 mM acetic acid for 20 h (4 C) with light agitation. Sam-
ples were centrifuged at 24000g for 1 h (4 C) and separated by tak-
ing 0.5 mL of the supernatant and leaving the remaining 0.5 mL of
supernatant with the pellet to minimize disruption. Supernatant
and pellet samples were hydrolyzed by adding 0.5 mL of 12 M HCl
to each (6 M final concentration) and boiling at 110 C over night
in a tightly sealed polypropylene tube (Safe-T-Seal, 1420–9701,
USA Scientific Inc.). Hydrolyzed samples were dried on a heat block
at 95 C, washed with 1 mL of distilled water and dried again. As a
measure of collagen content, the collagen ‘‘specific” amino acid
Fig. 1. Schematic of fibril sample preparation (Section 2.7 for details). 1) Achilles and tail tendon fascicles taken for fibril testing. Tail fascicles were also prepared for
macroscopic mechanical testing with ink marks. 2) Fibrils spread onto a silicon substrate. 3) A separate fibril is enclosed by a ring of epoxy glue. 4) Polystyrene spheres
adsorbed to fibril for optical tracking. 5) Epoxy ring is partly released from substrate. The detached (bottom) part of the ring appears brighter with scratches from the
scraping, while the top part is still attached and appears darker. 6) Epoxy ring with fibril is mounted in the opening of an aluminum foil window. Just before mechanical
testing the two wings (pointing up and down) are cut. 7) Microscopy image of the sample on the window.
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assay based on 4-dimethylaminobenzaldehyde (method details in
Supplement S1.1) [42]. Solubility was determined as the HYP con-
tent in the supernatant divided by the total HYP content in the pellet
and supernatant.
2.4. Fluorescence
Several of the products formed by glycation are fluorescent [43],
and total fluorescence can be used as an indirect measure of AGE
modification [44,45]. Tissue was hydrolyzed and as a measure of
collagen content, HYP was determined in an aliquot by the assay
mentioned above (Supplement S1.1). Aliquots of the remaining
hydrolysate were diluted 1, 5, 25 and 125 fold in an acetate-
citrate buffer used for the HYP assay (0.55 M acetate, 0.13 M
citrate, pH 6.0). Samples (200 mL) were added to the wells of a
96-well plate and fluorescence measured (CytoFluor4000, Applied
Biosystems) at wavelengths 360/40 nm (excitation) and 460/40
nm (emission). A plateau effect could be seen for some of the high
concentration samples and only values with a linear relation to
concentration were used. Fluorescence values were normalized
to HYP content.
2.5. Enzymatic cross-links
Mature enzymatic pyridinoline cross-links, hydroxylysyl
pyridinoline (HP) and lysyl pyridinoline (LP), were evaluated by
HPLC. Samples (2 mg) underwent gas-phase hydrolysis for 24 h
at 110 C using 37% HCl containing 0.3% phenol. Air was removed
from the hydrolysis vessel by three consecutive applications of
vacuum and nitrogen, ending with vacuum. Resulting hydrolysates
were vacuum dried at room temperature over night, re-dissolved
in 2 M HCl and aliquots containing approximately 0.3 mg sample
were taken for analysis. Aliquots were vacuum dried and re-
dissolved in 75 mL of 1% heptafluorobutyric acid (HFBA) containing
an internal standard of 2 mM pyridoxamine dihydrochloride.Separation was on a reversed phase column (Kinetex 2.6 mm C18
100 Å, Phenomenex) using a non-linear decreasing gradient
(91%–77.6%) of eluent A (25 mM NH4OH, 10 mM HFBA (pH 2.4))
against eluent B (25% eluent A, 75% acetonitrile with 10 mMHFBA).
Quantification was based on standards of HP and LP (PYD/DPD
HPLC Calibrator, 8004, Quidel Corp.).
2.6. Fascicle mechanics
Fascicles were marked with a black pen at two locations (2
mm apart) for optical strain tracking. Ink did not enter the fascicle
but formed a dry ‘‘crust” on the surface. Fascicles were glued with
cyanoacrylate at a nominal gauge length of 20 mm onto the clamps
of a microtensile tester (200-N tensile stage, petri dish version,
Deben) equipped with a 20 N load cell. The glue cured for 30 min
while the free part of the fascicle was hydrated by a strip of PBS
soaked tissue paper. Samples were loaded to an onset force of
0.01 N for 4-week old tails and 0.05 N for 16-week old tails (due
to their larger diameter) followed by 10 cycles of preconditioning
to 1.5% strain. The fascicle was loaded to the onset point and the
width and thickness (using a 45 mirror) measured on microscope
images at three locations. Finally the sample was loaded to failure
with simultaneous video recording (18 Hz) for use in optical strain
tracking. All tests were conducted at a speed of 4 mm/min. Track-
ing of optical strain markers was performed using the ‘‘Tracker”
open-source software [46]. Optical and mechanical data were man-
ually synchronized to the start of motor movement and the failure
point. Modulus was determined as the peak value of a moving
linear fit over a 1% strain window.
2.7. Fibril mechanics
See Fig. 1 for a schematic overview of the sample preparation. A
1 mm long piece of a single fascicle was divided longitudinally and
the exposed surface sheared across a silicon substrate under a
droplet of PBS. The sample was rinsed in distilled water and blown
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>100 mm long) were located in an optical microscope with dark-
field illumination. Using a thin hair, a ring of two-component
epoxy glue (Epoxy Extra Strong, Bostik) was placed around the fib-
rils to just cover the ends. The epoxy cured at ambient conditions
for at least 24 h, and then a 20 mL droplet of 1 mm polystyrene
beads (Polybead Microspheres, Polysciences Inc) diluted to 0.625
mg/mL in PBS was placed on the sample for 15 min to adsorb opti-
cal markers onto fibrils for strain analysis (Fig. 2A). The sample was
rinsed with distilled water and blown dry with nitrogen. A central
part of each fibril was imaged with atomic force microscopy (AFM)
to determine the dry cross-sectional area as previously described
[47]. Finally the epoxy ring holding the fibril was released from
the surface by scraping with the tip of a 27 gauge syringe needle.
The ring was picked up with negative action tweezers and attached
to an aluminum foil ‘‘window” (Fig. 1) (50 mm thick) using hybrid
glue (Universal Hybrid Glue, Loctite) applied with a thin hair. Using
a laser microdissection microscope (Axio Observer Z1, Zeiss) the
epoxy ring was cut open, and then the aluminum foil window
was mounted on the custom built nanomechanical test device. A
detailed description of the device can be found in the Supplemen-
tary material (S1.2). In brief, the device uses a piezoelectric actua-
tor to apply deformation and a macroscopic cantilever together
with a capacitance sensor to measure force. The device can be
mounted on an inverted microscope to observe the fibril and mea-
sure strain optically. Using a chamber slide, the sample can be
immersed in liquid. The sample was attached to the device using
cyanoacrylate glue (Super Glue Precision, Loctite), which cured
for 30 min. The ‘‘wings” of the aluminum window were cut with
a micro-scissor and the device was placed on the microscope with
the sample immersed in PBS. After hydrating for 30 min the fibril
was gently stretched until a minimal force was detected, and then
a single linear ramp to failure was performed. The average strain
rate was 3.6%/s and varied (SD 1.2%/s) due to differences in fibril
length. Because the fibril was slack when immersed in PBS, it
would move around and often adsorb to the edges of the clamp.
During the ramp to failure it would then detach at low force and
once again get slack. In these cases the test was stopped, the fibril
was again stretched until almost taut and another ramp to failure
was performed.Fig. 2. A) Example optical strain tracking on a collagen fibril. Left and right sides are
the cantilever and piezo actuator respectively. Square boxes show the tracked
regions. (1) Slack fibril. (2) Taut fibril at the onset of force. (3) Last frame before
failure, showing the total strain, regional strains and strain excluding the ends. B)
Example stress-strain curves from fascicles with different age and treatment. C)
Example stress-strain curves from collagen fibrils with and without methylglyoxal
treatment. The onset deviates from zero stress because of baseline drift (details in
Supplement S1.2). Inset shows the modulus along the curves with arrows at the
first and second peak in the MG sample. Ctrl = untreated, MG = methylglyoxal
treated.2.8. Fibril data analysis
Optical markers on the fibrils were tracked using a customMat-
lab routine (MATLAB R2015b, MathWorks Inc.) based on cross-
correlation (Fig. 2A). To the extent possible a minimum spacing
between tracking points of 50 pixels (18 mm) was maintained
to reduce the strain measurement error, and consequently not all
optical markers were tracked on each fibril. To assess tracking
quality, pixel positions were high-pass filtered by subtracting a
moving average over 10 points (1 s) and determining the stan-
dard deviation of the remaining noise. Typical noise values were
between 0.2 and 1 pixel for stationary and fast moving points
respectively (points closer to the actuator move faster than points
near the stationary cantilever). The frame rate was not constant
during the microscope video recordings and as a result they could
not be directly synchronized to the mechanical data. To overcome
this issue, a point solidly connected to the piezo actuator was
tracked in the video and the movement of this point expressed rel-
ative to its total movement during the ramp. The same relative
motion from the piezo position sensor was also determined for
the ramp and the two data sets were synchronized (i.e. the frame
in which the video showed a relative piezo movement of X%, was
synchronized to the mechanical data where the position sensor
also reached X% of the total range).Optical deformation data (10 Hz) was upsampled and syn-
chronized to the mechanical data (400 Hz), and all the data was fil-
tered with a 40 point (0.1 s) wide moving average and finally
downsampled to 40 Hz before further analysis. Peak elastic modu-
lus was determined as the first peak value of a moving linear fit
over a 3% strain window (Fig. 2C inset). As described later, some
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denoted as ‘‘peak modulus” throughout refers only to the first peak
which is present in all samples. Note that all stress-related mea-
surements (stress and modulus) are based on dry fibril cross-
sectional areas.Fig. 3. A) Solubility of tendon collagen samples in 50 mM acetic acid. B) Fluores-
cence of tendon hydrolysates as indicator of AGE formation. Ctrl = untreated, MG =
methylglyoxal treated, HYP = hydroxyproline. Mean and SE.2.9. Statistics
Fascicle mechanical parameters were averaged across duplicate
samples from each animal before statistical analysis. In contrast,
fibril mechanical data was not averaged across animals because
it is the individual fibril responses that are of interest in this study.
Since the study had a full factorial design (2x2x2), a three-way
ANOVA (generalized linear model) was used with Tukey-Kramer
adjusted post tests. Initially, all interactions were included in the
analysis, if the third-order interaction was not significant it was
removed and the analysis repeated. Any of the three second-
order interactions that were not significant were removed and
the analysis repeated with the final model containing all the main
effects and any remaining significant interactions. Several of the
mechanical parameters showed a log-normal residual distribution
and since the remaining parameters were also well represented by
a log-normal distribution, all the mechanical data was log trans-
formed. Results are shown as back-transformed geometric means
and geometric standard errors. All parametric analyses were per-
formed in SAS (v.9.2, SAS Institute Inc.).
For the enzymatic cross-link measurement, one group had zero
HP content in all measurements, making parametric statistics
unsuitable. Instead separate rank-based Mann-Whitney U tests
were performed on the effect of age within each tissue and the tis-
sue difference at each age with Bonferroni correction for the four
comparisons (Prism 7, GraphPad software Inc.). For the sake of
comparability, the same analysis was made for the LP cross-links.3. Results
Group comparisons are presented as mean values (geometric
means for mechanical data) within the compared groups across
any uninvolved factors (i.e. for a main effect of treatment the mean
value of each treatment group is taken across all ages and tissue
types). Individual group values and standard errors are reported
in tables and figures. Tables displaying confidence intervals and
main effects of age, treatment and tissue type on fascicle and fibril
mechanics can be found in the Supplement (Tables S1–S3).3.1. Acid solubility
MG treatment resulted in completely insoluble samples (the
values shown represent the detection limit of the measurement)
(Fig. 3A). Since the Achilles tendons had lower solubility than the
tails, there was a two-way interaction between tissue type and
treatment (p < 0.0001), showing that the reduction with treatment
was smaller in the Achilles (9.1% vs. 0.3%, p < 0.05) (control vs.
treated) than in the tail (91.7% vs. 0.5%, p < 0.0001). Because acid
solubility of treated samples was at the detection limit in all
groups, the effects of age and tissue type were only assessed in
untreated samples. There were no interactions between age and
tissue type, but there was an effect of tissue type with Achilles ten-
dons having significantly lower acid solubility than tails (9.1% vs.
91.7%, p < 0.0001). Acid solubility was not significantly affected
by age, but tended to be lower in the older animals (46.9% vs.
54.0%, p = 0.07).3.2. Fluorescence
Fluorescence values are shown in Fig. 3B. There were two-way
interactions between age and tissue type (p < 0.01) as well as age
and treatment (p < 0.005). Analyzing these interactions showed
that fluorescence was not affected by age in the Achilles tendon
(9.9 vs. 8.9, p = 0.47) (4 week vs. 16 week) but reduced with age
in the tail tendons (11.1 vs. 7.2, p < 0.0001), and also that there
was no effect of age in controls (3.8 vs. 2.9, p = 0.52) but a reduc-
tion with age in MG treated samples (17.2 vs. 13.2, p < 0.0001)
(see discussion in Supplement S2.1). There was a significant
increase with MG treatment across tissues at both 4 weeks (3.8
vs. 17.2, p < 0.0001) and 16 weeks (2.9 vs. 13.2, p < 0.0001).
3.3. Enzymatic cross-links
Cross-link values for the untreated samples are shown in
Table 1. The concentration of HP was significantly higher in the
Achilles compared to the tail at both 4 weeks (90 vs. 0 mmol/mol,
p < 0.01) and 16 weeks (278 vs. 2 mmol/mol, p < 0.01). HP also
increased with age in both tails (0 vs. 2 mmol/mol, p < 0.01) and
Achilles (90 vs. 278 mmol/mol, p < 0.05). For LP there was a signif-
icant increase with age in the tail (8 vs. 21 mmol/mol, p < 0.01) but
no significant differences between any of the other groups.
3.4. Fascicle mechanics
Mechanical properties of tail fascicles using optical strain are
shown in Fig. 2B, Fig. 4A-C and Table 2. All mechanical parameters
increased with both age andMG treatment. Failure stress increased
with age (20 vs. 51 MPa, p < 0.0001) and MG treatment (20 vs. 50
MPa, p < 0.0001). Failure strain increased with age (3.8% vs. 6.7%, p
< 0.001) and MG treatment (3.5% vs. 7.3%, p < 0.0001). Failure
energy increased with age (0.3 vs. 1.3 MJ/m3, p < 0.0001) and MG
treatment (0.3 vs. 1.4 MJ/m3, p < 0.0001). Peak modulus increased
Table 1
Enzymatic cross-links normalized to molar collagen content. Median [1st-3rd quartile] (N).
Tail Tail Achilles Achilles
4 week 16 week 4 week 16 week
HP (mmol/mol) Ctrl 0 [0–0] (6) 2 [1–4] (6) 90 [70–106] (5) 278 [153–326] (6)
LP (mmol/mol) Ctrl 8 [7–8] (6) 21 [13–27] (6) 12 [1–13] (5) 13 [10–19] (6)
Ctrl = untreated.
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Fig. 4. Mechanical data. A, B, C) Failure strain, stress and peak modulus for fascicles. Based on optical strain measurement. D, E, F) Failure strain, stress and peak modulus for
fibrils. Based on optical strain measurement. Ctrl = untreated, MG = methylglyoxal treated. Geometric mean and geometric SE.
R.B. Svensson et al. / Acta Biomaterialia 70 (2018) 270–280 275with age (0.77 vs. 1.27 GPa, p < 0.0001) and MG treatment (0.88 vs.
1.11 GPa, p < 0.0005). There were no interactions, indicating that
the age difference remained the same after MG treatment. Nominal
failure strain was significantly greater than optical failure strain
(6.7% vs. 5.1%, p < 0.0001), but the mechanical properties behaved
similarly regardless of using optical or nominal strain, except that
the increase in modulus with MG treatment was not significant
using nominal strains.Fascicle diameter increased significantly with age (0.13 vs. 0.22
mm, p < 0.0001) but not with MG treatment. The tested segment
length was significantly greater in the 4-week old MG treated
group than any of the other groups (p < 0.005). This was due to
contraction after MG treatment resulting in a bit of curling (the
thicker 16-week old fascicles were less prone to curl). To investi-
gate if differences in diameter and length could underlie some of
the mechanical group differences the linear model was extended
Table 2
Fascicle mechanics from optical strains in the central region. Geometric mean
[geometric SE] (N).
Tail Tail
4 week 16 week
Length (mm) Ctrl 22.2 [22.0–22.4] (5) 21.9 [21.6–22.3] (6)
MG 24.4 [24.0–24.8] (6) 21.8 [21.6–22.0] (5)
Diameter (mm) Ctrl 0.13 [0.11–0.15] (5) 0.21 [0.17–0.25] (6)
MG 0.14 [0.12–0.17] (6) 0.23 [0.19–0.29] (5)
Failure Stress (MPa) Ctrl 13 [12–13] (5) 32 [29–36] (6)
MG 31 [26–36] (6) 81 [73–89] (5)
Failure Strain (%) Ctrl 2.3 [2.0–2.6] (5) 5.2 [4.3–6.1] (6)
MG 6.2 [5.6–6.8] (6) 8.5 [7.8–9.1] (5)
Failure Energy (MJ/m3) Ctrl 0.2 [0.1–0.2] (5) 1.0 [0.7–1.3] (6)
MG 0.7 [0.5–0.9] (6) 2.9 [2.4–3.5] (5)
Peak Modulus (GPa) Ctrl 0.68 [0.66–0.70] (5) 1.13 [1.10–1.16] (6)
MG 0.86 [0.79–0.93] (6) 1.43 [1.39–1.48] (5)
Ctrl = untreated. MG = methylglyoxal treated.
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results, except the effect of age on failure strain did not achieve sta-
tistical significance, but the magnitude of the effect remained the
same.
3.5. Local fibril strains
Of the 68 fibrils tested in this study 61 were successfully
marked with polystyrene beads for optical strain analysis (Table 3).
The ends were observed to strain substantially more than the cen-
tral region (20.6% vs. 14.1%, p < 0.0001) (Fig. 2A), which was likely
due to end-effects resulting from an imperfect interface to the
sample [48]. Therefore, the remaining analyses were performed
only on optical markers in the central region. Since the strain at
the ends was increased, the failure strain in the central region
was necessarily reduced from the nominal value (14.1% vs. 16.2%,
p < 0.0001) and modulus calculated from optical strain was conse-
quently increased (2.2 vs. 1.9 GPa, p < 0.0001). Uniformity of the
strain distribution was assessed by the standard deviation of
strains within the central region of each fibril. This standard devi-
ation was not dependent on the age, tissue or treatment group. At
the failure point the standard deviation was 2.1%, which is 15% ofTable 3
Fibril mechanics based on optical strains in the central region. Geometric mean [geometr
Tail Ta
4 week 16
Length (mm) Ctrl 144 [127–163] (7) 26
MG 202 [183–224] (8) 27
Dry Diameter (nm) Ctrl 143 [137–150] (7) 23
MG 162 [151–174] (8) 18
Failure Stress (MPa) Ctrl 120 [100–130] (7) 80
MG 560 [460–690] (8) 42
Failure Strain, Ends (%) Ctrl 18 [15–21] (7) 20
MG 31 [28–34] (8) 23
Failure Strain, Central (%) Ctrl 8.5 [7.4–9.8] (7) 8.
MG 22.9 [21.7–24.2] (8) 16
Failure Energy (MJ/m3) Ctrl 6 [5–8] (7) 5
MG 56 [46–67] (8) 29
Peak Modulus (GPa) Ctrl 2.2 [2.1–2.4] (7) 1.
MG 3.1 [2.6–3.6] (8) 2.
2nd Peak Modulus (GPa)a Ctrl (0) (0
MG 5.9 [4.1–8.4] (6) 6.
Strain SD within Fibrils (%)b Ctrl 1.8 [1.3–2.4] (6) 1.
MG 2.3 [1.8–3.0] (8) 1.
Ctrl = untreated. MG = methylglyoxal treated.
a Only including samples that had the three-phase behavior.
b Standard deviation (SD) of local strains within the central region of each fibril. Sam
measure one local strain in the central region and therefore no SD could be determinedthe total strain (14%) at that point. The average segment length
between two tracking points was 105 pixels, which means that
the 1 pixel tracking noise could account for about 1% variation
in strain.
Failure strain at the local site where rupture occurred was sig-
nificantly increased compared to the mean optical failure strain
in the central region (16.8% vs. 15.1%, p < 0.05) (discarding 25
(41%) tests where failure occurred in the end regions and an addi-
tional 2 (3%) tests where the number of strain markers was too low
(<5) to differentiate local strains within the central region).3.6. Fibril mechanics
Mechanical properties are reported using optical strain in the
central region (Fig. 2C, Fig. 4D–F, Table 3). None of the fibril
mechanical parameters were affected by age or tissue type, and
there were no significant three- or two-way interactions. However,
all of the mechanical parameters increased significantly with MG
treatment. Failure stress increased with MG treatment (110 vs.
460 MPa, p < 0.0001). Failure strain increased with MG treatment
(10.1% vs. 20.5%, p < 0.0001). Failure energy increased with MG
treatment (7 vs. 40 MJ/m3, p < 0.0001). Peak modulus increased
with MG treatment (1.9 vs. 2.6 GPa, p < 0.05). Using nominal strain,
group differences in mechanical parameters were equivalent to
those using the optical strain (i.e. no effect of age or tissue, but a
significant effect of MG treatment) (Table S4 in Supplement).
Fibril diameter varied across the groups, which resulted in a sta-
tistically significant three-way interaction (p < 0.005) (Fig. 5A).
There was no direct correlation between diameter and any
mechanical properties, but adding diameter to the linear model
showed a significant reduction of failure stress (r2 (semi-partial)
= 0.05, p < 0.01) and peak modulus (r2 (semi-partial) = 0.09, p <
0.01) with increasing diameter (Fig. 5B). Inclusion of diameter in
the ANOVA model did not change the effects of age, tissue type
and MG treatment.
A three-phase mechanical response that consisted of an initial
region of high modulus, followed by a plateau region of low
modulus leading to a second region of high modulus (Fig. 2C),
was present in 26 of the 34 MG treated fibrils (76%) and 2 of the
34 untreated fibrils (6%). Since few control fibrils displayed this
behavior, the effects of age and tissue type were only assessed inic SE] (N).
il Achilles Achilles
week 4 week 16 week
7 [240–298] (8) 231 [217–245] (8) 223 [200–248] (11)
0 [243–299] (10) 202 [176–232] (7) 187 [168–209] (9)
1 [209–255] (8) 110 [104–116] (8) 153 [146–161] (11)
0 [168–193] (10) 130 [121–141] (7) 201 [190–212] (9)
[70–100] (8) 110 [90–140] (8) 150 [120–190] (11)
0 [310–570] (10) 460 [360–590] (7) 410 [330–500] (9)
[16–25] (7) 13 [10–16] (8) 14 [11–18] (10)
[19–28] (9) 23 [20–26] (5) 37 [31–45] (7)
9 [7.1–11.2] (7) 11.5 [8.6–15.3] (8) 11.7 [10.0–13.9] (10)
.2 [13.2–20.0] (9) 19.1 [15.5–23.4] (5) 24.0 [22.9–25.2] (7)
[4–6] (7) 6 [4–10] (8) 10 [6–14] (10)
[18–46] (9) 29 [20–44] (5) 46 [39–55] (7)
6 [1.3–2.0] (7) 1.6 [1.2–2.0] (8) 2.0 [1.6–2.4] (10)
8 [2.4–3.1] (9) 2.1 [1.7–2.6] (5) 2.4 [2.3–2.6] (7)
) 0.8 [–] (1) 2.6 [-] (1)
0 [3.5–10.3] (6) 3.2 [2.7–3.9] (4) 4.7 [3.3–6.8] (6)
3 [1.0–1.9] (7) 1.3 [0.8–2.1] (8) 2.4 [1.8–3.1] (10)
6 [1.2–2.2] (9) 1.6 [1.0–2.4] (4) 1.5 [1.2–2.0] (5)
ple sizes are reduced because some samples only had enough strain markers (4) to
.
Fig. 5. Fibril diameter. A) Fibril diameter in each group. Mean and SE. B) Relation
between fibril peak modulus and fibril diameter. These correlations were not
directly significant, only after accounting for all group differences (Section 4.3 for
details). Ctrl = untreated, MG = methylglyoxal treated.
R.B. Svensson et al. / Acta Biomaterialia 70 (2018) 270–280 277the treated samples. Age and tissue type had no effect on either the
second peak modulus or the ratio between the second and first
peak modulus, but the second peak modulus was greater than
the first (4.1 vs. 2.3 GPa, p < 0.0001).
4. Discussion
Functionally distinct tendons have different mechanical
requirements, and mechanical function also develops during mat-
uration. Differences in naturally occurring cross-links often accom-
pany differences in tissue type and maturation and could be an
important contributor to mechanical function at the fibril level.
The differences in acid solubility and mature enzymatic HP cross-
links in the present tissues suggest variations in cross-link profile
that could affect fibril mechanics. MG treatment also successfully
modified the collagen as evidenced by the loss of solubility and rise
in fluorescence.
4.1. Animal maturity and tendon type
Since cross-links are located between collagenmolecules within
a collagen fibril they are expected to exert the strongest influence
on the fibril, with the effect getting attenuated at higher levels of
the structural hierarchy up to the macroscopic tendon. In contrast,
we have previously shown that treatment of tendon with NaBH4,
which chemically stabilizes immature enzymatic cross-links, had
a notable mechanical effect at the fascicle level, but not at the level
of individual fibrils [31]. Similarly, in the present study mechanical
properties of tail fascicles greatly increased in the more mature
animals, while individual fibrils were unaffected in spite of higher
HP concentration. This suggests that changes at the macroscopic
level did not originate in the material properties of fibrils butmay instead involve mechanisms such as increased fibril length
or interconnectedness. In addition, there were no significant differ-
ences in the behavior of fibrils from tail and Achilles tendons in
spite of their different functional roles at the macroscopic level.
The high acid solubility of tails, especially in the immature animals,
indicates a low level of stable mature and immature cross-links.
The lower solubility in Achilles tendons indicates a greater concen-
tration of stable cross-links and the higher content of HP suggests
that some of these are mature ketoamine cross-links. These results
indicate that fibrils from functionally different tendons do not
behave differently, in spite of differences in chemical stability
and enzymatic cross-links. It is possible that labile immature enzy-
matic cross-links are sufficient to provide mechanical reinforce-
ment, and non-labile and mature cross-links mainly contribute to
increasing chemical and not mechanical stability. It should be
noted that mechanical properties had a high variance, which could
mask some of the difference. The 95% confidence interval would for
example allow the Achilles fibrils to have between 20% lower and
54% higher stress than those from the tail (see Supplementary
Tables S1–S3).
4.2. Methylglyoxal treatment
MG treatment significantly increased all measured mechanical
properties at both the fascicle and fibril level. The relative magni-
tude of the increase was similar in fibrils and fascicles, although
the peak modulus, failure stress and failure energy increased more
in the fibrils (40%, 300%, 500%) than fascicles (25%, 150%, 380%),
while the relative increase in failure strain was similar (100%).
A detail worth noticing is that the MG treated fascicles had a longer
toe region (Fig. 2B), which we suspect is a result of increased bend-
ing stiffness of collagen fibers causing force to rise earlier during
re-alignment. Toe region length can be estimated by extrapolating
the linear part of the curve down to the strain-axis, which yields
0.3% for the controls and 2.4% for the MG treated, so at least part
of the increase in failure strain can be attributed to this increased
toe region length.
A previous study reported similar mechanical changes at the
fascicle level but found no effect on the stiffness or modulus of
the fibril [37]. Cross-linking is expected to mainly affect molecular
sliding [37,49] and consequently have a greater effect on failure
properties than on the first peak in modulus, which is achieved
before sliding begins. Although peak modulus increased in the pre-
sent work, it does not disagree with this theory since the effect was
seven times smaller than that on failure stress.
The majority of the MG treated fibrils displayed a third phase of
increasing stiffness in the stress-strain response, which was absent
in the majority of the controls. This behavior was related to fibril
strength with the strongest controls displaying it and the weakest
MG treated lacking it (Fig. S4 in Supplement). We have previously
observed a very similar mechanical response in collagen fibrils
from human patellar tendon compared to fibrils from rat tail
tendon [31]. We originally proposed that these differences were
due to higher concentrations of mature enzymatic pyridinoline
cross-links in human tendons compared to rat tails. The concentra-
tion of AGE cross-links was also greater in the human tendons, but
we initially surmised that AGE cross-links were less likely to cause
the mechanical differences, in part because the human tissue was
from young men (35 years) and in part because we expected
the more random nature of AGE cross-linking to result in uniform
stiffening rather than distinct phases. In contrast, enzymatic cross-
links occur at the telopeptide ends where unfolding of a particular
‘‘hairpin loop” could explain the plateau of low stiffness before the
third phase [50]. However, in light of the current results on MG
treatment and the lack of differences in fibril mechanics related
to differences in acid solubility and HP concentration, it seems
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observed mechanical behavior of human collagen fibrils, even at
a relatively young age. Note that the present study induced a sup-
raphysiological level of MG derived AGE cross-links, whereas the
glucose derived AGE cross-link glucosepane is likely more impor-
tant in vivo. Whether the effects of a physiological level of glucose
AGEs are similar remains to be tested.
That the unspecific formation of AGE cross-links result in three
mechanical phases, rather than uniform stiffening, indicates that
this is an inherent feature of collagen mechanics independent on
the specific cross-link site. This is supported by molecular simula-
tions of fibril mechanics, which have reported a similar three-
phase behavior where the plateau phase was due to molecular slip-
page and the final region of high modulus resulted from the end of
uncoiling and beginning of backbone stretching within collagen
molecules [51,52]. The simulation study also found that trivalent
cross-links reinforced the fibril more strongly than divalent ones
[51], but in the present work the higher levels of trivalent pyridino-
line cross-links in Achilles did not appear to affect fibril mechanics,
however, possible differences in other trivalent cross-links are
unknown. It should be noted that the important factor is the total
number of neighboring molecules connected by the cross-links,
and trivalent cross-links may connect the same set of molecules
as the divalent ones. Since MG derived cross-links can occur at
many sites along the fibril, their effective valence can be higher,
possibly explaining the greater mechanical influence.
4.3. Fibril structure-mechanics relationship
Fibril diameter has been suggested to affect mechanical proper-
ties, and there is some evidence of this at the macroscopic level
[53,54]. At the fibril level a reduction in yield stress with increasing
fibril volume has also been reported [55]. Some of the proposed
mechanisms relate to higher levels of the hierarchy, such as
reduced sliding of small fibrils due to larger relative surface area,
but others relate to the fibril itself. It has been proposed that large
fibrils would be stiffer and stronger due to fewer cross-linking sites
being ‘‘wasted” on the surface [54], however, the opposite could
also be true if the chemical modifications required for cross-
linking occur more easily at the surface. A related observation is
the possible existence of a core-shell structure in fibrils [56],
although other reports have not supported this notion [57]. In
the present data there was a negative correlation between diame-
ter and stress-related mechanical parameters (failure stress, peak
modulus) when all group differences were accounted for
(Fig. 5B). MG treatment may have limited penetration into the fib-
rils, which could drive this correlation via relatively higher cross-
linking of thinner fibrils. Analyzing the treated and control samples
separately did not reveal a significant relation to diameter in either
group, and in Fig. 5B the two groups also appear to behave simi-
larly. A relation between stress and diameter could be driven by
errors in the AFM based diameter measurement. However, artifacts
in AFM usually overestimate the dimensions leading to underesti-
mated stress values, and this error would be relatively greater for
small fibrils. The AFM based error would therefore result in
increasing stress with diameter, contrary to our results. Overall
there is some evidence for a reduction of mechanical properties
with increasing fibril diameter, but the low correlation coefficient
and the fact that it is not significant within treatment groups sep-
arately weakens this conclusion.
4.4. Local fibril strain
A key advantage of the newmechanical test system is the ability
to observe the fibril with light microscopy during mechanical test-
ing,whichenables theuseof local strainmarkers todetermine straindistribution.While therewas somevariation in strain along thefibril
it was generally uniform except for the ends where strain was con-
sistentlyhigher than in the central part. The strain at failurewas1.7%
greater (11% relative increase) in the regionwhere rupture occurred.
To determine if there was a consistent strain concentration at the
rupture site, the strain difference at 75% of the failure load was also
determined, but there was no conclusive evidence for an inherent
weakness (p = 0.19). Electron microscopy has previously been used
to show the existence of local regions of disruption in collagenfibrils
following mechanical damage [39] and we had hypothesized that
this mechanism could give rise to local regions of increased strain,
however, such strain concentration was not clear from the data. It
is possible that fibril strain is simply uniform, and the structures
observed with electron microscopy are not caused by an inherent
property of the fibrils but may result from stress concentrations
due to uneven stress transmission from the surrounding matrix.
Alternatively, the disrupted regions may only have a small effect
on strain and theobservedvariationof a fewpercent could represent
these regions. It is also possible that the distance between the beads
in the present work (25–100 mm) is large enough that each such
range stretches over several regions of localized strain concentra-
tions, thereby averaging them out.
4.5. Overall fibril mechanics
To our knowledge, the three-phase behavior has only been
reported experimentally by our group [31]; however, the present
study reproduced this observation by using substantially different
equipment and sample preparations than previously. We believe
this supports the validity of the observation.
In absolute terms the results are in the same range as our previ-
ous studies using AFM, but we generally obtain lower values of
stress, strain and modulus than previously. The most comparable
data is between the present 16 week old untreated tail fibrils and
the rat tail fibrils in Svensson et al. [31], where the failure stress, fail-
ure strain andpeakmoduluswere 250 MPa, 17% and2.6 GPa respec-
tively, compared to the present 80 MPa, 8.9% and 1.6 GPa (using
optical strain). While technical sources of error may play a role, we
suspect that an important part of the difference is due to the very
short fibril segments tested previously (35 mm) compared to the
present study (270 mm) since the probability of having a local
weakness along the fibril increases with length (i.e. the chain not
being stronger than the weakest link) [58]. This may also be part
of the reason for the large variation in failure stress (Fig. 4E).
For comparison to the fascicle level, the estimated swelling on
hydration (30%) [59] and volume fraction of hydrated fibrils
within a hydrated tail tendon (75%) can be taken into account
[60]. Since there were no significant differences between age
groups and tissue types the average across all the untreated sam-
ples is used: 110 MPa failure stress, and 1.8 GPa peak modulus
(using optical strain), which is then equivalent to 50 MPa and 0.8
GPa at the fascicle level. These represent upper bounds on the val-
ues achievable in fascicles if no additional strain and failure mech-
anisms were present between the fibril and fascicle levels. The fact
that the measured fascicle modulus exceeds the upper bound
expected from the fibril measurements indicates an underestimate
at the fibril level. Based on our findings, a possible explanation is
the previously mentioned decrease with diameter (Fig. 5B) causing
an underestimate of stress and modulus due to the lack of small
diameter fibrils in our data. Another factor may be a general over-
estimate of fibril diameter in AFM images.
4.6. Limitations
An important limitation in this study is the drying/rehydration
of fibrils required for sample preparation, which may affect the
R.B. Svensson et al. / Acta Biomaterialia 70 (2018) 270–280 279mechanical properties. To shed some light on this we examined the
acid solubility and mechanical properties of tail fascicles after 1
week of drying followed by rehydration. Acid solubility decreased
and peak modulus, failure stress and failure strain increased, but
the effects were insufficient to obscure the underlying age differ-
ences, suggesting that drying alone cannot explain the lack of dif-
ferences at the fibril level (details in Supplement S2.2). A recent
study has focused on preparing fibril samples fully hydrated, but
to our knowledge the optical trap utilized cannot achieve sufficient
load for a failure test [61]. The long storage period before fibril test-
ing could also be an issue, however, the fascicle mechanics in sup-
plement S2.2 were recorded after fibril testing and still displayed
the age differences seen in the original tests. In addition, a recent
study found no mechanical effects at the micro scale after frozen
storage of tail tendon for up to 6 months [62]. None the less, the
effects of long term frozen storage on fibril mechanics remain an
unknown factor, which could affect our results.
Another limitation is an inherent selection bias of the tested
fibrils. First, there is a size bias because fibrils are located with
an optical microscope, making it largely impossible to test fibrils
below 80 nm. Second, there is a potential overestimate of fibril
strength since weaker fibrils are more likely to break during
preparation, thereby never completing the mechanical test. This
is supported by the observation that 58% the mechanically weaker
control fibrils and only 39% of the MG treated fibrils broke during
preparation, however, there was less difference between young
(57%) and old (44%) as well as tail (53%) and Achilles (50%). It
therefore seems unlikely that the mechanical bias affected the
comparison of maturation and tissue type substantially.
Only pyridinoline cross-links were directly measured and while
acid solubility may serve as an indicator of labile aldimine cross-
links, it is not possible to assess changes in other cross-links,
including immature ketoamine as well as mature pyrrole and
histidine derived cross-links [27]. General conclusions regarding
enzymatic cross-linking are therefore tentative.
A final limitation is the lack of viscoelastic mechanical tests
such as stress-relaxation or creep, which could be more sensitive
to some mechanical changes [37]. We were unable to perform such
tests with our equipment because the dynamic range is limited by
high frequency noise above 30 Hz and low frequency fluctuations
over several seconds (details in Supplement S1.2).5. Conclusion
Counter to our initial hypotheses, the level of mature pyridino-
line cross-linking had little to no effect on fibril mechanics. AGE
induction with MG did increase fibril strength and stiffness as
expected, but also increased ultimate strain leading to stronger
and tougher fibrils rather than more brittle ones. There was an
increased local strain near the rupture site of the fibrils, but the dif-
ference was relatively small and, within experimental variations,
the overall strain was evenly distributed over the fibril length. Also
counter to expectations, AGE induction did not affect the
uniformity of local strains. Finally, AGE treatment resulted in a
three-phase mechanical response very similar to what has previ-
ously been seen in young adult human tendons, suggesting that
AGEs may play an important mechanical role in human tendons,
even before old age.Acknowledgements
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